Bartonellosis is an infectious disease caused by bacteria of the genus Bartonella.
Presentation
Carrión's disease
Patients can develop two clinical phases: an acute septic phase and a chronic eruptive phase associated with
dermatology lesions.
In the acute phase (also known as
Oroya fever or
fiebre de la Oroya),
B. bacilliformis infection is a sudden, potentially life-threatening infection associated with high
fever and decreased levels of circulating red blood cells (i.e.,
hemolytic anemia) and transient immunosuppression.
B. bacilliformis is considered the most deadly species to date, with a death rate of up to 90% during the acute phase, which typically lasts two to four weeks. Peripheral blood smears show anisomacrocytosis with many
bacilli adherent to red blood cells.
Thrombocytopenia is also seen and can be very severe. Neurologic manifestations (neurobartonellosis) are altered mental status, agitation, or even coma, ataxia, spinal
meningitis, or
paralysis. It is seen in 20% of patients with acute infection, in which the
prognosis is very guarded with about 50% mortality. The most feared complication is an overwhelming infection mainly by Enterobacteriaceae, particularly
Salmonella (both
S. typhi and
S. non-
typhi, as well as reactivation of
toxoplasmosis and other opportunistic infections.
The chronic manifestation consists of a benign skin eruption with raised, reddish-purple nodules (angioma). The bacterium can be seen microscopically if a skin biopsy is (the Warthin–Starry method).
Cat-scratch disease
Cat-scratch disease is due to an infection by
B. henselae. It manifests as gradual regional
lymph nodes enlargement (
axilla,
groin,
neck) which may last 2–3 months or longer, and a distal
scratch and/or red-brown skin
papule (not always seen at the time of the disease). The enlarged lymph node is painful and tender. The lymph nodes may suppurate, and some patients remain afebrile or asymptomatic. Other presentations include fever (particularly in children), Parinaud's oculoglandular syndrome,
encephalopathy, and neuroretinitis.
[Breitschwerdt, EB. Bartonella sp. Bacteremia in Patients with Neurological and Neurocognitive Dysfunction. JOURNAL OF CLINICAL MICROBIOLOGY. Sept. 2008. 46(9): 2856–2861]
B. henselae can be associated with bacteremia, bacillary angiomatosis, and peliosis hepatis in HIV patients, and bacteremia and endocarditis in immunocompetent and immunocompromised patients.[Faherty, CS. Staying alive: bacterial inhibition of apoptosis during infection . Trends in Microbiology (16:4). 175.] Disease progression may be accelerated if the host is subsequently infected by an immune-suppressing virus such as Epstein-Barr.
Bacillary angiomatosis
B. henselae and
B. quintana can cause bacillary angiomatosis, a
Blood vessel proliferative disease involving mainly the skin, and other organs. The disease was first described in human immunodeficiency virus (HIV) patients and
organ transplant recipients.
Severe, progressive and disseminated disease may occur in HIV patients.
Differential diagnoses include Kaposi's sarcoma,
pyogenic granuloma,
hemangioma,
verruga peruana, and subcutaneous tumors. Lesions can affect
bone marrow,
liver,
spleen, or
lymph nodes.
Peliosis hepatis
B. henselae is the etiologic agent for peliosis hepatis, which is defined as a vascular proliferation of sinusoid hepatic
capillaries resulting in blood-filled spaces in the liver in HIV patients and organ transplant recipients. Peliosis hepatis can be associated with peliosis of the spleen, as well as bacillary angiomatosis of the skin in HIV patients.
Trench fever
Trench fever, also known as five-day fever or quintan fever, is the initial manifestation of
B. quintana infection. Clinical manifestations range from asymptomatic infection to severe illness. Classical presentations include a febrile illness of acute onset,
headache,
dizziness, and
Tibia pain. Chronic infection manifestations include attacks of fever and aching in some cases and persistent bacteremia in
soldiers and
homeless people.
Microbiology
Members of the genus
Bartonella are facultative intracellular bacteria, alpha 2 subgroup
Pseudomonadota. The genus comprises:
|
|
| Bartonella bacilliformis | human | Carrion's disease / verruga Peruana |
| Bartonella quintana | human | Trench fever, bacteremia, bacillary angiomatosis, endocarditis |
| Bartonella henselae | cats | Cat-scratch disease, bacillary angiomatosis, bacteremia, endocarditis, encephalitis, meningitis |
| Bartonella elizabethae | rats | Endocarditis |
| Bartonella grahamii | | Retinitis |
| Bartonella vinsoni | dogs | Endocarditis, bacteremia |
| Bartonella washonsis | rodents | Myocarditis |
| Bartonella clarridgiae | cats | Bacteremia |
| Bartonella rochalimae | human | Carrion's disease-like syndrome |
Pathophysiology
In mammals, each
Bartonella species is highly adapted to its reservoir host as the result of intracellular parasitism and can persist in the host's bloodstream. Intraerythrocytic parasitism is only observed in the acute phase of Carrion's disease.
Bartonella species also have a tropism for endothelial cells, observed in the chronic phase of Carrion's disease (also known as
verruga Peruana) and bacillary angiomatosis.
Pathological response can vary with the immune status of the host. Infection with
B. henselae can result in a focal suppurative reaction (CSD in immunocompetent patients), a multifocal angioproliferative response (bacillary angiomatosis in immunocompromised patients),
endocarditis, or
meningitis.
Diagnosis
There are several methods used for diagnosing
Bartonella infection including
microscopy,
serology, and PCR.
of blood smears is used to diagnose Carrión's disease (
B. bacilliformis), however for other
Bartonella species, microscopy and
are insensitive, not highly specific, and cannot differentiate species.
The CDC does not recommend lymph node aspiration for diagnostic purposes.
Serology and protein-based methods
IFA (immunofluorescence
antibody assay) testing for the presence of antibodies in serum is used to diagnose
B. henselae infection at the acute onset of Cat Scratch Disease symptoms, followed by PCR to confirm infecting species.
IFA can generally be used to confirm a diagnosis of
Bartonella infection but is limited by antibody cross-reactivity with other bacteria species
which can cause a false positive, and antigen variability which can result in false negatives.
Bartonella spp. often evade an immune response, thus antibodies may not be detected even concurrent with an infection, resulting in an IFA false negative rate of up to 83% in chronically infected patients when other test results (e.g. organism isolation or PCR) are positive.
ELISA is another method that has been used to detect Bartonella, but it has a low sensitivity (17-35%).
PCR
The CDC states that PCR testing from a single blood draw is not sufficiently sensitive for
B. henselae testing,
and can result in high false negative rates
due to a small sample volume and levels below the limit of molecular detection.
Bartonella spp. are fastidious, slow-growing bacteria that are difficult to grow using traditional solid agar plate culture methods due to complex nutritional requirements and potentially a low number of circulating bacteria.
Enrichment Culture
Bartonella growth rates improve when cultured in an enrichment inoculation step in a liquid insect-based medium
such as
Bartonella Alphaproteobacteria Growth Medium (BAPGM)
or Schneider's Drosophila-based insect powder medium.
Several studies have optimized the growing conditions of
Bartonella spp. cultures in these liquid media, with no change in bacterial protein expressions or host interactions
in vitro.
Insect-based liquid media supports the growth and co-culturing of at least seven
Bartonella species,
reduces bacterial culturing time and facilitates PCR detection and isolation of
Bartonella spp. from animal and patient samples.
Research shows that DNA may be detected following direct extraction from blood samples and become negative following enrichment culture, thus PCR is recommended after direct sample extraction and also following incubation in enrichment culture.
Several studies have successfully optimized sensitivity and specificity by using PCR amplification (pre-enrichment PCR) and enrichment culturing of blood draw samples, followed by PCR (post-enrichment PCR) and DNA sequence identification.
Serial Testing
As
Bartonella spp. infect at low levels and cycle between blood and tissues,
multiple blood draws over time may be necessary to detect infection.
Treatment
Treatment of infections caused by
Bartonella species include:
|
|
| Cat-scratch disease | Azithromycin + Rifampin | Unknown |
| Retinitis | Doxycycline + rifampin | unknown |
| Trench fever or chronic bacteremia by B. quintana | Doxycycline + gentamicin | unknown |
| Bacillary angiomatosis | Erythromycin or doxycycline | Erythromycin |
| Peliosis hepatis | Erythromycin or doxycycline | Erythromycin |
| Endocarditis | Doxycycline + gentamicin + rifampin or ceftriaxone + gentamicin | |
| Carrión's disease (acute phase) | Ciprofloxacin or chloramphenicol | Chloramphenicol + beta-lactam |
| Carrión's disease (chronic phase) | Rifampin or macrolides | Rifampin or macrolides |
Some authorities recommend the use of azithromycin.
Epidemiology
Carrión's disease, or Oroya fever or Peruvian wart is a rare infectious disease found only in
Peru,
Ecuador, and
Colombia.
It is endemic in some areas of
Peru,
is caused by infection with the
bacterium Bartonella bacilliformis, and transmitted by
sandfly of
genus Lutzomyia.
Cat scratch disease occurs worldwide. Cats are the main reservoir of Bartonella henselae,
Trench fever, produced by Bartonella quintana infection, is transmitted by the human body louse Pediculus humanus corporis. Humans are the only known reservoir.
A possible role for ticks in the transmission of Bartonella species remains to be elucidated; in November 2011, Bartonella rochalimae, B. quintana, and B. elizabethae DNA was first reported in Rhipicephalus sanguineus and Dermacentor nitens ticks in Peru.
History
Carrión's disease
The disease was named after medical student Daniel Alcides Carrión from Cerro de Pasco,
Peru. Carrión described the disease after being inoculated at his request with the pus of a skin lesion from patient Carmen Paredes in 1885 by Doctor Evaristo M. Chávez, a close friend and coworker in Dos de Mayo National Hospital. Carrión developed the disease three weeks after the inoculation and kept a meticulous record of clinical symptoms and signs until the disease rendered him incapable of the task and he died at age 28 several weeks later—October 5, 1885. Carrión proved that Oroya fever and
verruga peruana were two stages of the same disease and not two different diseases as was thought at the time. His work did not result in a cure immediately, but his research started the process. Peru has named October 5 as "Peruvian Medicine Day" in his honor.
Peruvian microbiologist Alberto Barton discovered the causative bacterium in 1905, but his results were not published until 1909. Barton originally identified them as "endoglobular" structures, bacteria living inside red blood cells. Until 1993, the genus Bartonella, within the family Bartonellaceae, contained only one species; 23 are now identified.
CSD
In 1988, English
et al. isolated and cultured a bacterium that was named
Afipia felis in 1992 after the team at the Armed Forces Institute of Pathology that discovered it. This agent was considered the cause of cat-scratch Disease (CSD) but further studies failed to support this conclusion. Serologic studies associated CSD with
Bartonella henselae, reported in 1992. In 1993, Dolan
isolated
Rochalimae henselae (now called
Bartonella henselae) from lymph nodes of patients with CSD.
Bartonella spp. are commonly treated with antibiotics including azithromycin, based on a single small randomized clinical trial. Treatment may take up to one year to eliminate the disease.
CSD often resolves spontaneously without treatment.
Trench fever
Detailed descriptions of the disease were reported in soldiers during the First World War. It is also known as five-day fever, quintan fever, Wolhinie fever, and urban trench fever because it occurs in homeless people and alcoholics .
External links
